本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

X4製藥

4.30
+0.600016.22%
盤後4.300.00000.00%19:45 EDT
成交量:26.52萬
成交額:111.58萬
市值:2,489.13萬
市盈率:1.99
高:4.35
開:3.83
低:3.83
收:3.70
資料載入中...
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/29

重要事件披露

Form 8-K - Current report
2024/04/29

重要事件披露

Form 8-K - Current report
2024/04/05

重要事件披露

Form 8-K - Current report
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans